Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002652250 | SCV003529193 | uncertain significance | Inborn genetic diseases | 2021-11-15 | criteria provided, single submitter | clinical testing | The c.2672G>T (p.C891F) alteration is located in exon 20 (coding exon 20) of the CUBN gene. This alteration results from a G to T substitution at nucleotide position 2672, causing the cysteine (C) at amino acid position 891 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |